Hemington Wealth Management Agios Pharmaceuticals, Inc. Transaction History
Hemington Wealth Management
- $398 Million
- Q4 2024
A detailed history of Hemington Wealth Management transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Hemington Wealth Management holds 26 shares of AGIO stock, worth $883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26
Previous 16
62.5%
Holding current value
$883
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
236Shares Held
58.2MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$192 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$188 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$165 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$127 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$96.2 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.86B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...